What are you looking for?

Patient Recruitment Case Study: Crohn’s Disease

A series of Phase 3 clinical trials evaluating ozanimod for people with moderately to severely active Crohn’s disease

THE CLINICAL TRIAL
The YELLOWSTONE Program is a suite of four phase 3, randomized, double-blind, placebo-controlled, multi-center studies that are evaluating the efficacy and safety of ozanimod, an investigational oral medication being studied for individuals with moderately to severely active Crohn’s disease. Ozanimod is an oral medication, not a biologic, injection or infusion. In the YELLOWSTONE PROGRAM, the investigational medication will be taken once daily. Ozanimod is also being studied for the treatment of multiple sclerosis.

Patient recruitment Crohn's disease clinical study poster branding and marketing materials
Patient recruitment Crohn's disease clinical study guide branding and marketing materials
Patient recruitment Crohn's disease clinical study brochure branding and marketing materials
Patient recruitment Crohn's disease clinical study

Put our solutions to work for your next clinical trial.

Back Top